Training
Training
Academic institutions can use Drug Discovery Pro’s comprehensive training programs to empower their researchers with cutting-edge computational skills and methodologies. While our platform currently offers a catalog of pre-recorded online courses, workshops, and programs, we also provide live, interactive training sessions tailored to the specific needs of your university or research institute.
These live training programs offer an economical way for your organization to upskill teams and communities of researchers simultaneously in the latest drug discovery techniques. Delivered by seasoned academics with over 10 years of classroom teaching experience, our training resources are designed to support the ongoing professional development of faculty, students, and industry partners working in the field of drug discovery.
We have the training programs in the form of two panels:
1- Live, real-time training
2- Self-paced, pre-recorded courses
Meet our training instructors
Prof. Dr. Khaled Barakat
Dr. Barakat earned his PhD in biophysics from the University of Alberta in 2012 and subsequently completed a two-year postdoctoral fellowship in the lab of Nobel Laureate Professor Michael Houghton. His research lies at the multidisciplinary intersection of physics,
biology, and computer science, focusing on understanding the structure-function relationship of cardiac ion channels in both health and disease. He is also committed to developing and applying advanced computational drug discovery tools to identify new antiviral and immunotherapeutic small-molecule drugs.
Dr. Barakat has received numerous awards, including the CIHR and AIHS postdoctoral fellowships and distinction awards during his undergraduate and graduate studies. He served as an editor for several scientific journals. He led a research lab supported by various funding agencies such as the Alberta Cancer Foundation, LiKa Shing Applied Virology Institute, Natural Sciences and Engineering Research Council (NSERC), LiKa Shing Institute of Virology, and IC-IMPACTS Centers of Excellence.
In addition, Dr. Barakat is the CEO and co-founder of HEKA Therapeutics Inc. and a co-founder of ACHLYS, two spinoff companies focused on drug discovery for immune checkpoint small molecule inhibitors and predicting off-target toxicity of new compounds in drug development.
Prof. Dr. Nadia Hamdy
Professor Nadia Hamdy’s research focuses on the (epi)genetic influences on the incidence, risk, prognosis, and treatment of non-communicable diseases (NCDs). She is the founder and director of the Clinical Biochemistry Genetics Research Group (CBGRG) .
Professor Hamdy has been committed to several projects funded by notable organizations, including the NIH/AHA, European PRIMA, Erasmus+, ASRT-Egypt, STDF Egypt, the Higher Ministry of Education (MHE) Egypt, the Academy of Scientific Research and Technology (ASRT) Egypt, and Ain Shams University (ASU). She has published over 75 papers and has an h-index of 26. In recognition of her work, she has received several prestigious awards, including the International Wendy Harvan Top Honorary Award & Certificate in February 2023, the Paola Sassone-Corsi Top Award in February 2021, and ASU’s first Best Scientific Project Research Topic in 2021. Additionally, she has been honored by WOE, SHE, BioScience, EVA, and 40over40 from 2020 to 2023.
Dr. Hamdy collaborated on the Global Burden of Disease (GBD) project and was an ambassador for the European Association for Cancer Research (EACR) and Bentham Publisher. She is a member of several international organizations and associations, including the UN GM, the Biochemical Society, FEBS, IFCC, the MENA Chapter of ISPE, ESMO, AAPS, and AAAS. Furthermore, she is a fellow of MHE Egypt, ASU, and ASRT-Egypt, among others.
Additionally, Professor Hamdy is a member of the editorial boards for “Frontiers in Oncology,” PLOS ONE, Discover Oncology, and Cancer Reports. She also contributes as an academic and scientific reviewer for numerous international journals. Prof. Hamdy has supervised 50 master’s theses and doctoral research projects.
Prof. Dr. Noha Yousri
Prof. Noha A. Yousri conducts research in collaboration with others that involves genomics and metabolomics data. She focuses on integrating multi-omics data related to diseases, utilizing metabolomics, genomics, epigenetics, and proteomics.
To date, she has authored and co-authored over 65 papers in the fields of bioinformatics and machine learning, achieving an h-index of 25. Additionally, she has worked on metabolomics related to Type 2 Diabetes (T2D) and rheumatoid arthritis.
Prof. Dr.Shaymaa Kassab
Prof. Kassab is interested in enhancing the selectivity of traditional therapeutics for specific isozymes associated with diseases, aiming to reduce the side effects caused by inhibition. Dr. Kassab is actively involved in projects focused on developing selective COX-2 inhibitors.
with minimal cardiovascular complications and selective histone deacetylase inhibitors that exhibit reduced cytotoxic side effects.
She recently authored a book chapter titled Indomethacin: From Anti-Inflammatory to Anticancer Agent in a medicinal chemistry publication (ISBN 978-953-51-6985-7). She is now an official reviewer for The European Journal of Medicinal Chemistry, ACS Omega, Journal of Medicinal Chemistry, Bioorganic Chemistry, and Frontiers in Chemistry journals.
Dr. Kassab has made significant contributions by promoting laboratory-friendly reaction conditions and minimizing the number of chemical steps required to create new drug candidates, thus facilitating the synthesis and scalability of these drugs. Additionally, she is the principal investigator of a research project funded by the Science and Technology Development Fund (STDF), which focuses on designing selective estrogen receptor full antagonists through the structural manipulation of partial agonists. Furthermore, Dr. Kassab played a vital role in the national campaign, Egypt Free from Virus C.
Live, Real-time Training
Workshops
Courses
Programs
Workshops
Workshops for Practical Mastery of Computational Drug Discovery Processes
Our workshops provide learning and practice in essential computational processes in drug discovery. Through each workshop, learners gain technical proficiency in using software and applications independently in their drug discovery research. Trainees learn beyond the ‘button clicks’ of the software; they are equipped with the know-how to troubleshoot, interpret, and present the results.These sessions are standalone and can be taken in any order.
Physicochemical properties calculations and visualizing the correlation coefficient…
Virtual Screening in silico analysis Importance, and in-silico experiment…
Physicochemical properties calculations and visualizing the correlation coefficient…
Using artificial intelligence to optimize synthetic routes, identify potential…
Reaction Enumeration Algorithms: Develop computational tools to enumerate all…
Computational pharmaceutics is a multidisciplinary field that integrate…
Courses
Our courses focus on the theoretical basis of the course topic. Minimal practical work is conducted during these sessions.
Virtual High Throughput Screening (vHTS) is a computational approach used…
Structure-activity relationship (SAR) studies are a critical part of medicinal chemistry…
Programs
A suite of combined theoretical and practical programs on computational drug discovery tools, tailored to the needs of academic researchers, from beginners to advanced learners.
The drug Discovery cycle consists of basic stages that must be completed for…
Mathematical concepts of coordinate systems, series expansion, vectors, matrix notations, and complex numbers…
Bioinformatics is a multidisciplinary field that merges biology, computer science, and information technology to analyze and …